280 related articles for article (PubMed ID: 33203198)
21. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
Pang L; Cheng Y; Zou S; Song J
Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes of downregulation of E-cadherin gene expression in non-small cell lung cancer.
Zheng SY; Hou JY; Zhao J; Jiang D; Ge JF; Chen S
Asian Pac J Cancer Prev; 2012; 13(4):1557-61. PubMed ID: 22799366
[TBL] [Abstract][Full Text] [Related]
23. Research progress concerning m
Zhou Y; Yang J; Tian Z; Zeng J; Shen W
Oncol Lett; 2021 Nov; 22(5):775. PubMed ID: 34589154
[TBL] [Abstract][Full Text] [Related]
24. Methylation of RNA N
Chang G; Leu JS; Ma L; Xie K; Huang S
Cytokine; 2019 Jun; 118():35-41. PubMed ID: 30017390
[TBL] [Abstract][Full Text] [Related]
25. The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer.
Yu J; Bulk E; Ji P; Hascher A; Tang M; Metzger R; Marra A; Serve H; Berdel WE; Wiewroth R; Koschmieder S; Müller-Tidow C
Clin Cancer Res; 2010 Apr; 16(8):2275-83. PubMed ID: 20371680
[TBL] [Abstract][Full Text] [Related]
26. Methylation-mediated loss of SFRP2 enhances invasiveness of non-small cell lung cancer cells.
Zhang X; Rong X; Chen Y; Su L
Hum Exp Toxicol; 2018 Feb; 37(2):155-162. PubMed ID: 29320940
[TBL] [Abstract][Full Text] [Related]
27. Circ_0000079 Decoys the RNA-Binding Protein FXR1 to Interrupt Formation of the FXR1/PRCKI Complex and Decline Their Mediated Cell Invasion and Drug Resistance in NSCLC.
Chen C; Zhang M; Zhang Y
Cell Transplant; 2020; 29():963689720961070. PubMed ID: 32951448
[TBL] [Abstract][Full Text] [Related]
28. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
Front Oncol; 2021; 11():635329. PubMed ID: 33928028
[TBL] [Abstract][Full Text] [Related]
29. Advances in the functional roles of N6-methyladenosine modification in cancer progression: mechanisms and clinical implications.
Chen P; Hu J; Han X; Chen Y
Mol Biol Rep; 2022 Jun; 49(6):4929-4941. PubMed ID: 35025029
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of m
Sun S; Han Q; Liang M; Zhang Q; Zhang J; Cao J
Thorac Cancer; 2020 Nov; 11(11):3269-3279. PubMed ID: 32956555
[TBL] [Abstract][Full Text] [Related]
31. Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1.
Ye Z; Shen N; Weng Y; Li K; Hu L; Liao H; An J; Liu L; Lao S; Cai S
Cancer Biol Ther; 2015; 16(7):1071-9. PubMed ID: 25961369
[TBL] [Abstract][Full Text] [Related]
32. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis.
Fu J; Cai H; Wu Y; Fang S; Wang D
Gene; 2020 Sep; 755():144886. PubMed ID: 32534055
[TBL] [Abstract][Full Text] [Related]
33. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
Vallböhmer D; Brabender J; Yang D; Schneider PM; Metzger R; Danenberg KD; Hölscher AH; Danenberg PV
Clin Lung Cancer; 2006 Jul; 8(1):39-44. PubMed ID: 16870044
[TBL] [Abstract][Full Text] [Related]
34. N
Dong L; Cao Y; Hou Y; Liu G
J Cell Physiol; 2022 Jan; 237(1):329-345. PubMed ID: 34515345
[TBL] [Abstract][Full Text] [Related]
35. miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124.
Gao Y; Fan X; Li W; Ping W; Deng Y; Fu X
Biochem Biophys Res Commun; 2014 Mar; 446(1):179-86. PubMed ID: 24582749
[TBL] [Abstract][Full Text] [Related]
36. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
37. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
[TBL] [Abstract][Full Text] [Related]
38. Clinical implication of microrna for lung cancer.
Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
[TBL] [Abstract][Full Text] [Related]
39. Functions of RNA N
Zheng X; Gong Y
Biomark Res; 2021 May; 9(1):36. PubMed ID: 34001273
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]